Are receptors promiscuous? Intrinsic efficacy as a transduction phenomenon

doi:10.1016/0024-3205(88)90467-5

Life Sciences

Volume 43, Issue 14, 1988, Pages 1095-1101

https://doi.org/10.1016/0024-3205(88)90467-5 Get rights and content

Abstract

The classical pharmacologic scales of agonist affinity and relative intrinsic efficacy, as utilized for drug and drug receptor classification, are examined in terms emerging concepts of receptor signal transduction. Specifically, evidence is considered that within the membrane of some cells, receptors may couple to more than one type of G-protein after agonist activation and that the relative dependence of response to different coupling proteins would make agonist efficacy a tissue dependent and not strictly a receptor dependent property. Since efficacy would depend upon the chemical nature of at least two receptor recognition domains (an extracellular domain for agonist recognition and a cytosolic domain for G-protein recognition), and agonist and antagonist affinity would depend upon only one, quantitative classification data utilizing these two scales would be divergent.

References (40)

E.E. Quist
Biochem. Pharmacol.
(1982)
T. Asano et al.
J. Biol. Chem.
(1984)
R.A. Cerione et al.
J. Biol. Chem.
(1986)
K. Haga et al.
J. Biol. Chem.
(1986)
J.H. Brown et al.
J. Biol. Chem.
(1984)
J. Garcia-Sainz
Trends Pharmacol. Sci.
(1987)
E. Kelly et al.
Eur. J. Pharmacol.
(1985)
T. Murayama et al.
J. Biol. Chem.
(1985)
T. Murayama et al.
J. Biol. Chem.
(1987)
O. Hazeki et al.
J. Biol. Chem.
(1981)

M. De Vivo et al.

Eur. J. Pharmacol.

(1985)

T.P. Kenakin

Trends Pharmacol. Sci.

(1982)

R.P. Ahlquist

Amer. J. Physiol.

(1948)

E.J. Ariens

Arch. Int. Pharmacodyn. Ther.

(1954)

R.P. Stephenson

Br. J. Pharmacol.

(1956)

R.F. Furchgott

T.P. Kenakin

Pharmacologic Analysis of Drug Receptor Interaction

(1987)

P. Cuatrecasas

Annu. Rev. Biochem.

(1974)

S. Jacobs et al.

Biochem. Biophys. Acta.

(1976)

R.B. Meeker et al.

Mol. Pharmacol.

(1982)

Cited by (42)

Steroid promiscuity: Diversity of enzyme action
2015, Journal of Steroid Biochemistry and Molecular Biology
This Special Issue on the topic of Steroid and Sterol Signaling: Promiscuity and Diversity, dwells on the growing realization that the ‘one ligand, one binding site’ and ‘one enzyme, one reaction’ concepts are out of date. Focusing on cytochromes P450 (CYP), hydroxysteroid dehydrogenases (HSDs), and related enzymes, the Special Issue highlights that a single enzyme can bind to diverse substrates, and in different conformations, and can catalyze multiple different conversions (and in different directions), thereby, generating an unexpectedly wide spectrum of ligands that can have subtly different biological actions.
This article is part of a Special Issue entitled ‘Steroid/Sterol Signaling’ .
5-HT<inf>1A</inf> receptor-mediated apoptosis: Death by JNK?
2007, Biochimica et Biophysica Acta - Molecular Cell Research
There is growing interest in the potential use of 5-HT_1A receptor agonists as neuroprotective agents in stroke and tramautic brain injury. However, a new study using a recombinant 5-HT_1A receptor cell line suggests that these agonists may promote as well as inhibit apoptotic responses. Because heterologously expressed receptors may couple promiscuously to inappropriate signal transduction pathways, the results should be interpreted with caution.
Pharmacological techniques for the in vitro study of intestinal smooth muscles
2001, Journal of Pharmacological and Toxicological Methods
Transgenic overexpression of β<inf>2</inf>-adrenergic receptors in airway smooth muscle alters myocyte function and ablates bronchial hyperreactivity
1999, Journal of Biological Chemistry
β₂-Adrenergic receptors (β₂AR) act to relax airway smooth muscle and can serve to counteract hyperresponsiveness, although the effect may not be ablative even in the presence of exogenous agonist. Within this signaling cascade that ultimately transduces smooth muscle relaxation, a significant “spare receptor” pool has been hypothesized to be present in the airway. In order to modify the relationship between β₂AR and downstream effectors, transgenic mice (TG) were created overexpressing β₂AR ∼75-fold in airway smooth muscle using a mouse smooth muscle α-actin promoter. While >90% of these receptors were expressed on the smooth muscle cell surface, the percentage of receptors able to form the agonist-promoted high affinity complex was less than that found with nontransgenic (NTG) cells (R_H = 18 versus 36%). Nevertheless, β₂AR signaling was found to be enhanced. Intact airway smooth muscle cells from TG had basal cAMP levels that were greater than NTG cells. A marked increase in agonist-stimulated cAMP levels was found in the TG (∼200% stimulation over basal) compared with NTG (∼50% over basal) cells. Adenylyl cyclase studies gave similar results and also showed a 10-fold lower EC₅₀for TG cells. Tracheal rings from TG mice that were precontracted with acetylcholine had an enhanced responsiveness (relaxation) to β-agonist, with a 60-fold decrease in the ED₅₀, indicating that the enhanced signaling imposed by overexpression results in an increase in the coordinated function of the intact airway cells. In vivo studies showed a significantly blunted airway resistance response to the inhaled bronchoconstrictor methacholine in the TG mice. Indeed, with β-agonist pretreatment, the TG mice displayed no response whatsoever to methacholine. These results are consistent with β₂AR being the limiting factor in the transduction system. Increases in the initial component of this transduction system (the β₂AR) are sufficient to markedly alter signaling and airway smooth muscle function to the extent that bronchial hyperresponsiveness is ablated, consistent with an anti-asthma phenotype.
The elusive nature of intrinsic efficacy
1998, Trends in Pharmacological Sciences
In the discipline of pharmacology, drugs (ligands) are used as tools to elucidate the processes of biological systems. Because of this, pharmacologists strive to delineate all characteristics of drugs. Decades of research have resulted in the proposal that ligands possess two properties that are intrinsic to the ligand and are invariant of the system in which their effects are investigated. These properties are affinity (the capacity of a drug to bind to a receptor) and intrinsic efficacy (the capacity of a drug to activate or inactivate a receptor). Although affinity is a relatively easy parameter to measure with a variety of techniques, ways of quantifying intrinsic efficacy have remained elusive ever since its inception. Furthermore, recent evidence suggests that intrinsic efficacy might not be a single, ligand-dependent parameter but that agonists might have multiple intrinsic efficacies. William Clarke and Richard Bond discuss several reasons why the claim that intrinsic efficacy is a ligand-dependent parameter should be questioned, and the possible impact of these findings.
Chronic treatment with antipsychotic drugs does not alter G protein α or β subunit levels in rat brain
1996, Neuropharmacology
Groups of rats received once daily subcutaneous treatments for 22 days with haloperidol (0.5 mg/kg), clozapine (20 mg/kg), SCH 23390 (0.2 mg/kg) or vehicle. Quantitative immunoblots for G_iα1, G_iα2, G_oα, G_sα (45 kD), G_β35 and G_β36 were performed on membranes from the following brain regions: striatum, nucleus accumbens, substantia nigra, ventral tegmental area (VTA), prefrontal cortex and hippocampus (CA1). No significant alterations were found in the levels of any of these G protein subunits, in any brain region in treated vs control rats. © 1997 Elsevier Science Ltd. All rights reserved.

View all citing articles on Scopus

View full text

MinireviewAre receptors promiscuous? Intrinsic efficacy as a transduction phenomenon

Abstract

Biochem. Pharmacol.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

Trends Pharmacol. Sci.

Eur. J. Pharmacol.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

Eur. J. Pharmacol.

Trends Pharmacol. Sci.

Amer. J. Physiol.

Arch. Int. Pharmacodyn. Ther.

Br. J. Pharmacol.

Pharmacologic Analysis of Drug Receptor Interaction

Annu. Rev. Biochem.

Biochem. Biophys. Acta.

Mol. Pharmacol.

Minireview
Are receptors promiscuous? Intrinsic efficacy as a transduction phenomenon